Fatigue assessment in Egyptian patients with hepatitis C virus-related chronic liver disease: Single center study

Figure 1 Prevalence of significant fatigue among chronic hepatitis C virus infected patients.

Figure 2 Prevalence of significant fatigue in different chronic hepatitis C virus infected patients. A: Prevalence of significant fatigue stratified according to age; B: Prevalence of significant fatigue stratified according to gender; C: Prevalence of significant fatigue stratified according to clinical stage of liver disease; D: Prevalence of significant fatigue stratified according to Child classification; E: Prevalence of significant fatigue stratified according to degree of fibrosis according to fibrosis-4. FIB-4: Fibrosis-4.

Figure 3 Prevalence of significant fatigue according to different 20-item multidimensional fatigue inventory subscales in chronic hepatitis C virus infected patients. MFI-20: 20-item multidimensional fatigue inventory.

Figure 4 Different dimensions of fatigue caused by different factors. A: Prevalence of significant 20-item multidimensional fatigue inventory (MFI-20) subscales significant fatigue stratified according to clinical stage of liver disease; B: Prevalence of MFI-20 subscales significant fatigue stratified according to Child classification. ^aP < 0.05.

Figure 5 Illustrated correlation between total fatigue score and other variable. A: Correlation between total 20-item multidimensional fatigue inventory (MFI-20) fatigue score and meld score (r = 0.819, P = 0.013); B: Correlation between total MFI-20 fatigue score and duration of hepatitis C virus infection/years. HCV: Hepatitis C virus.